Product Details for: Esperoct
RETURN TO SEARCH RESULTS
PRODUCT LABEL
Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
For Injection
Intravenous
3000IU
Single-Dose Vial
351(a)
Esperoct
Rx
002
For Injection
Intravenous
1000IU
Single-Dose Vial
351(a)
Esperoct
Rx
003
For Injection
Intravenous
2000IU
Single-Dose Vial
351(a)
Esperoct
Rx
004
For Injection
Intravenous
500IU
Single-Dose Vial
351(a)
Esperoct
Rx
005
For Injection
Intravenous
1500IU
Single-Dose Vial
351(a)
Esperoct
Rx
006
For Injection
Intravenous
4000IU
Single-Dose Vial
351(a)
Esperoct
Rx
007
For Injection
Intravenous
5000IU
Single-Dose Vial
351(a)
Esperoct
Rx
Proper Name
Antihemophilic Factor (Recombinant), GlycoPEGylated-exei
Antihemophilic Factor (Recombinant), GlycoPEGylated-exei
BLA Number
125671
125671
Applicant
Novo Nordisk Inc.
Novo Nordisk Inc.
Original Approval Date
February 19, 2019
February 19, 2019
Date of First Licensure